Mr. Speaker, yesterday was a momentous day for Canadian health care. Bill C-64, the Pharmacare Act, received royal assent. This landmark legislation will establish a framework for national, publicly funded, single-payer universal drug coverage; it will ensure that Canadians across the country have access to the diabetes medications and contraception they need.
Can the Parliamentary Secretary to the Minister of Health share with the House what passing this landmark pharmacare legislation will mean for the health of Canadians?